Makindo Medical Notes"One small step for man, one large step for Makindo" |
![]() |
---|---|
Download all this content in the Apps now Android App and Apple iPhone/Pad App | |
MEDICAL DISCLAIMER: The contents are under continuing development and improvements and despite all efforts may contain errors of omission or fact. This is not to be used for the assessment, diagnosis, or management of patients. It should not be regarded as medical advice by healthcare workers or laypeople. It is for educational purposes only. Please adhere to your local protocols. Use the BNF for drug information. If you are unwell please seek urgent healthcare advice. If you do not accept this then please do not use the website. Makindo Ltd. |
Related Subjects: | Leukaemias in General | Acute Promyelocytic Leukaemia | Acute Myeloblastic Leukaemia (AML) | Acute Lymphoblastic Leukaemia (ALL) | Chronic Lymphocytic Leukaemia (CLL) | Chronic Myeloid Leukaemia (CML) | Hairy Cell Leukaemia | Differentiation Syndrome | Tretinoin (ATRA) | Haemolytic Anaemia | Immune Thrombocytopenic Purpura (ITP)
𧬠Leukaemia is a malignant disorder of the blood and bone marrow characterised by uncontrolled proliferation of abnormal white blood cells. This disrupts normal haematopoiesis β causing anaemia, bleeding, and infection. Different types of leukaemia vary in onset, severity, and prognosis, but all require timely recognition and treatment.
Type | Incidence | Notes |
---|---|---|
ALL πΆ | ~9% | Most common childhood leukaemia; rapid progression if untreated. |
CML π | ~10% | Adults; linked to Philadelphia chromosome; average age ~64 yrs. |
CLL π΄ | ~23% | Slow buildup of abnormal B cells; commonest leukaemia in elderly. |
AML π§ | ~27% | Bone marrow packed with myeloid blasts; most cases >50 yrs. |
Myeloproliferative Disorders π | ~31% | Include polycythaemia vera, myelofibrosis, essential thrombocythaemia. |
Category | Key Facts |
---|---|
π¬ Definition | Malignant proliferation of abnormal WBCs in bone marrow β disrupts normal haematopoiesis (anaemia, infection, bleeding). |
π Classification |
|
π§Ύ Common Types |
|
β οΈ Symptoms |
|
π§ͺ Key Investigations |
|
π Management |
|
π Prognosis |
|
π‘ Exam Tip: Think βAnaemia, Infection, Bleedingβ as the classic triad of leukaemia presentation. Always mention bone marrow biopsy for diagnosis and TKIs for CML in finals!
Prognosis depends on type, age, and cytogenetics. β Childhood ALL β cure rates >80%. β CML β near-normal life expectancy with tyrosine kinase inhibitors. β οΈ AML in elderly β poorer prognosis, but improving with novel therapies. Overall, advances in precision medicine and stem cell transplantation continue to improve survival outcomes.